These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3259909)

  • 41. Single-dose treatment of acute cystitis with fosfomycin tromethamine.
    Stein GE
    Ann Pharmacother; 1998 Feb; 32(2):215-9. PubMed ID: 9496408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic activity of fosfomycin simulating urinary concentrations achieved after a single 3-g oral dose versus Escherichia coli using an in vitro model.
    Zhanel GG; Parkinson K; Higgins S; Denisuik A; Adam H; Pitout J; Noreddin A; Karlowsky JA
    Diagn Microbiol Infect Dis; 2017 Jul; 88(3):271-275. PubMed ID: 28483306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].
    Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV
    Urologiia; 2009; (3):18-21. PubMed ID: 19670810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
    Naber KG; Schito G; Botto H; Palou J; Mazzei T
    Eur Urol; 2008 Nov; 54(5):1164-75. PubMed ID: 18511178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis].
    Ohkawa M; Yamaguchi K; Orito M; Shimamura M; Hirano S; Hisazumi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1800-5. PubMed ID: 3502225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
    Patel SS; Balfour JA; Bryson HM
    Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
    Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
    Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of bacterial cystitis with a single dose of trimethoprim, co-trimoxazole or amoxycillin compared with a course of trimethoprim.
    Bailey RR; Keenan TD; Eliott JC; Peddie BA; Bishop V
    N Z Med J; 1985 May; 98(779):387-9. PubMed ID: 3887254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacteriostatic and bactericidal activity of two trimethoprim-sulfonamide combinations.
    Böhni E
    Chemotherapy; 1976; 22(3-4):262-73. PubMed ID: 1269292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fosfomycin trometamol: activity in vitro against urinary tract pathogens.
    Greenwood D
    Infection; 1990; 18 Suppl 2():S60-4. PubMed ID: 2286463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H; Veyries ML; Levacher M; Garnier M; Aymard G; Giroud JP; Rouveix B
    Therapie; 2000; 55(6):691-7. PubMed ID: 11234464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic progress: trimethoprim-sulfamethoxazole.
    Ruiz López R; Saavedra S; Ramírez-Ronda CH
    Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
    [No Abstract]   [Full Text] [Related]  

  • 56. The trometamol salt of fosfomycin: microbiological evaluation.
    Greenwood D; Coyle S; Andrew J
    Eur Urol; 1987; 13 Suppl 1():69-75. PubMed ID: 3552702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers.
    Wijma RA; Huttner A; van Dun S; Kloezen W; Abbott IJ; Muller AE; Koch BCP; Mouton JW
    Int J Antimicrob Agents; 2019 Oct; 54(4):435-441. PubMed ID: 31382030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
    Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
    Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency].
    Fillastre JP; Leroy A; Josse S; Moulin B
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.